Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We hypothesized that molecular-based phenotypic characterization of TNBC tumors and their immunity may overcome these challenges. We enr...

Full description

Bibliographic Details
Main Authors: Cun Liu, Ye Li, Xiaoming Xing, Jing Zhuang, Jigang Wang, Chunyan Wang, Lujun Zhang, Lijuan Liu, Fubin Feng, Huayao Li, Chundi Gao, Yang Yu, Jingyang Liu, Changgang Sun
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
triple-negative breast cancer
immune risk signature
risk stratification
tumor immune microenvironment types
treatment strategy
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253122001111

Internet

http://www.sciencedirect.com/science/article/pii/S2162253122001111

Similar Items